Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies
Sign Up to like & getrecommendations! Published in 2021 at "Cancer"
DOI: 10.1002/cncr.33457
Abstract: Immuno‐oncology therapies have been approved for various solid tumors; however, the high cost of these treatments and their potential toxicities require a thorough assessment of their risks and benefits. Collection of data directly from patients… read more here.
Keywords: solid tumors; immuno oncology; health related; oncology therapies ... See more keywords
PP113 Reimbursement Of Oncology Therapies With Limited Clinical Evidence In The Netherlands
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462322002367
Abstract: Introduction The number of novel therapies that achieve registration in oncology based on limited clinical evidence like non-randomized studies (NRS) is increasing. Dutch health authorities determine the therapeutic value of medicines evaluated in randomized controlled… read more here.
Keywords: oncology; clinical evidence; oncology therapies; evidence ... See more keywords